Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren’s syndrome: examination of data from the UK Primary Sjögren’s Syndrome Registry

OBJECTIVES To assess the use of the Clinical EULAR Sjögren’s Syndrome Disease Activity Index (ClinESSDAI), a version of the ESSDAI without the biological domain, for assessing potential eligibility and outcomes for clinical trials in patients with primary Sjögren’s syndrome (pSS), accord...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Alexandre Dumusc, Wan-Fai Ng, Katherine James, Bridget Griffiths, Elizabeth Price, Colin T. Pease, Paul Emery, Peter Lanyon, Adrian Jones, Michele Bombardieri, Nurhan Sutcliffe, Costantino Pitzalis, Monica Gupta, John McLaren, Annie Cooper, Ian Giles, David Isenberg, Vadivelu Saravanan, David Coady, Bhaskar Dasgupta, Neil McHugh, Steven Young-Min, Robert J. Moots, Nagui Gendi, Mohammed Akil, Francesca Barone, Benjamin A. Fisher, Saaeha Rauz, Andrea Richards, Simon J. Bowman, Swiss Medical Weekly
Formatua: Artikulua
Hizkuntza:English
Argitaratua: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2018-02-01
Saila:Swiss Medical Weekly
Gaiak:
Sjögren’s
clinical trial
eligibility
registry
outcome
ClinESSDAI
Sarrera elektronikoa:https://www.smw.ch/index.php/smw/article/view/2444

Internet

https://www.smw.ch/index.php/smw/article/view/2444

Antzeko izenburuak